Strokes attributable to underuse of warfarin and antiplatelets
- 30 April 2005
- journal article
- Published by Elsevier in Journal Of Stroke & Cerebrovascular Diseases
- Vol. 14 (2) , 55-57
- https://doi.org/10.1016/j.jstrokecerebrovasdis.2004.11.003
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Anticoagulation Therapy for Stroke Prevention in Atrial FibrillationJAMA, 2003
- Anticoagulant-Related Bleeding in Older Persons With Atrial FibrillationArchives of internal medicine (1960), 2003
- Lessons from the Stroke Prevention in Atrial Fibrillation TrialsAnnals of Internal Medicine, 2003
- Underuse of aspirin in a referral population with documented coronary artery diseaseThe American Journal of Cardiology, 2002
- Why Do Patients With Atrial Fibrillation Not Receive Warfarin?Archives of internal medicine (1960), 2000
- Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyAnnals of Internal Medicine, 1999
- Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitalsNeurology, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of strokeJournal of the Neurological Sciences, 1996
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994